High-Dose REirradiation for In-Field Recurrent Longkanker in the THOrax (RETHO): Uitkomsten of a Fase 2-Prospectieve Klinische trial

Locoregional failures after (chemo)radiation therapy for primary lung cancer account for 30% of relapses. Reirradiation in this setting is challenging. To evaluate the outcome after thoracic reirradiation with radical doses, a prospective phase 2 trial was conducted for marginal or in-field recurrences of lung cancer.